Charlottesville, VA, United States of America

Mark Sigman


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1988-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Sigman: Innovator in Forensic Analysis

Introduction

Mark Sigman is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of forensic science, particularly through his innovative patents. With a total of 2 patents, Sigman's work focuses on developing tools that enhance the analysis of sexual assault evidence.

Latest Patents

Sigman's latest patents include a monoclonal antibody to MHS-5, which specifically binds to a seminal vesicle specific antigen (SVSA). This antigen is secreted by the principal cells of the seminal vesicle epithelium. The method for producing this monoclonal antibody is also disclosed in his patent. Additionally, he has developed a new probe for forensic analysis of sexual assaults, which utilizes the monoclonal antibody to a new protein marker, MHS-5, found in semen. This probe is designed to assist in the forensic analysis of criminal evidence, providing a valuable tool for law enforcement.

Career Highlights

Mark Sigman is affiliated with the University of Virginia, where he continues to advance his research and innovation in forensic science. His work has the potential to significantly impact the field, providing new methodologies for analyzing evidence in sexual assault cases.

Collaborations

Some of his notable coworkers include John C Herr and William M Sutherland, who contribute to the collaborative efforts in research and development at the University of Virginia.

Conclusion

Mark Sigman's contributions to forensic analysis through his innovative patents highlight the importance of scientific advancements in the field. His work not only enhances the capabilities of forensic investigations but also serves as a testament to the impact of dedicated research in improving public safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…